Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.

Gastroenterology
Neeraj K SaxenaFrank A Anania

Abstract

Epidemiological studies have shown that obesity is a risk factor for hepatocellular carcinoma (HCC). Lower adiponectin levels are associated with poor prognosis in obese HCC patients, hence it is plausible that adiponectin acts as a negative regulator of HCC. We investigated the effects of adiponectin on HCC development and its molecular mechanisms. Assays with Huh7 and HepG2 HCC cells were used to examine the signal transduction pathways involved in the protective functions of adiponectin in HCC. These studies were followed by in vivo approaches using HCC xenografts and tumor analysis. Results from in vitro and in vivo findings were corroborated using human HCC tissue microarray and analysis of clinicopathological characteristics. Adiponectin increased apoptosis of HCC cells through activation of caspase-3. Adiponectin increased phosphorylation of c-Jun-N-terminal kinase (JNK) and inhibition of c-Jun-N-terminal kinase-phosphorylation inhibited adiponectin-induced apoptosis and caspase-3 activation. Adiponectin increased phosphorylation of 5'-adenosine monophosphate-activated protein kinase and tumor suppressor tuberous sclerosis complex 2 and inhibited mammalian target of rapamycin phosphorylation. Inhibition of 5'-adenosine m...Continue Reading

References

Nov 10, 1995·The Journal of Biological Chemistry·P E SchererH F Lodish
May 12, 1994·Nature·J M KyriakisJ R Woodgett
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H MøllerJ H Olsen
May 3, 1996·The Journal of Biological Chemistry·E HuB M Spiegelman
Apr 29, 1998·International Journal of Urology : Official Journal of the Japanese Urological Association·Y FuruyaH Ito
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·L C Cantley, B G Neel
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
May 24, 2003·Current Diabetes Reports·Utpal B Pajvani, Philipp E Scherer
Jun 13, 2003·Nature·Toshimasa YamauchiTakashi Kadowaki
Jul 4, 2003·The Journal of Clinical Investigation·Aimin XuGarth J S Cooper
Feb 6, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Jean M RegimbeauJacques Belghiti
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Barry J Goldstein, Rosario Scalia
Aug 21, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Neeraj K SaxenaFrank A Anania
Aug 28, 2004·Endocrinology·Maofu FuRichard G Pestell
Sep 11, 2004·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·Ekaterina A EfimovaA K Nüssler
Oct 19, 2004·Medical Hypotheses·Omer Dizdar, Evrim Alyamaç
Oct 29, 2004·Journal of Cell Science·D Grahame Hardie
Nov 24, 2004·Nature Medicine·Rei ShibataKenneth Walsh
Jan 20, 2005·Journal of Internal Medicine·M E Trujillo, P E Scherer
Mar 23, 2005·Current Opinion in Cell Biology·Dietmar E Martin, Michael N Hall
Mar 23, 2005·Current Opinion in Pharmacology·Ruth E Gimeno, Lori D Klaman
May 4, 2005·The Journal of Allergy and Clinical Immunology·Giamila Fantuzzi
May 18, 2005·Endocrine Reviews·Takashi Kadowaki, Toshimasa Yamauchi
Jun 7, 2005·Biochemical and Biophysical Research Communications·Toshiaki MiyazakiYoshiki Iwamoto
Oct 11, 2005·Drug Discovery Today·Andrea R Nawrocki, Philipp E Scherer
Apr 15, 2006·The Journal of Physiology·Hiroyuki MotoshimaEiichi Araki
Jun 13, 2006·Trends in Endocrinology and Metabolism : TEM·Blerina KolaMárta Korbonits
Feb 20, 2007·Biochimica Et Biophysica Acta·Gary L Johnson, Kazuhiro Nakamura

❮ Previous
Next ❯

Citations

Jan 5, 2011·Antioxidants & Redox Signaling·Maurizio Parola, Fabio Marra
Jan 11, 2013·Gastroenterology Research and Practice·Shintaro FujiharaTsutomu Masaki
Jul 8, 2011·Cancer Prevention Research·Mohammad Athar, Levy Kopelovich
Jan 5, 2011·Arthritis Research & Therapy·Eun Ha KangYeong Wook Song
May 2, 2012·Endocrine Reviews·Maria DalamagaChristos S Mantzoros
Aug 25, 2012·World Journal of Gastroenterology : WJG·Hayato Nakagawa, Shin Maeda
Oct 1, 2011·Gastroenterology Research and Practice·Shen-Nien WangKing Teh Lee
Jan 30, 2013·Journal of Cancer Research and Clinical Oncology·Eun ShinHye Seung Lee
Nov 28, 2013·Clinics in Liver Disease·Ester Vanni, Elisabetta Bugianesi
Aug 21, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Geoffrey Farrell
Jun 22, 2011·Clinics in Liver Disease·Asma Siddique, Kris V Kowdley
Nov 22, 2014·Biomolecules & Therapeutics·Saroj Nepal, Pil-Hoon Park
Nov 19, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·J Chen
Oct 5, 2012·European Journal of Clinical Investigation·Shen-Nien WangYao-Tsung Yeh
Apr 14, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hayato NakagawaShin Maeda
Jan 10, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lars P BechmannAli Canbay
Nov 14, 2012·The British Journal of Surgery·F CauchyJ Belghiti
Dec 21, 2010·International Journal of Cancer. Journal International Du Cancer·Toru AranoKazuhiko Koike
Feb 14, 2013·International Journal of Cancer. Journal International Du Cancer·Xiao-Feng DuanZhen-Tao Yu
Mar 22, 2014·Journal of Cellular Physiology·Carola PorcileAurora Daniele
Jul 7, 2015·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tomohiko OhnoHisataka Moriwaki
Nov 14, 2014·Clinical Endocrinology·C H LeeK S L Lam
Jul 30, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Naoto FujiwaraKazuhiko Koike
Dec 11, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Rong-Rong Song, Xiao-Lin Gu
Nov 29, 2011·Journal of Hepatology·Beicheng Sun, Michael Karin
Feb 28, 2016·Digestive Diseases and Sciences·Helen L ReevesChristopher P Day
Dec 4, 2012·Cancer Letters·Roslyn VongsuvanhDavid van der Poorten
Sep 11, 2013·Seminars in Cancer Biology·Yuan TianAlfred Sze-Lok Cheng
Jun 6, 2012·Pathology Research International·Hayato Nakagawa, Shin Maeda
Jul 11, 2014·Cytokine & Growth Factor Reviews·Ganji Purnachandra NagarajuOlatunji Boladale Alese

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis